TAG:
american association of clinical chemistry
“October 23, 2000 Intelligence: Late Breaking Lab News”
Get ready for the stock market to begin creating multi-millionaires from today’s generation of commercial laboratory executives. Most laboratorians know that Roche sold $430.5 million of its stock holding in Laboratory Corporation of America stock only seven days a…
New Blood Entering the Lab Industry
SURPRISE! THERE’S A QUIET MANAGEMENT REVOLUTION UNDER WAY in both the clinical laboratory industry and pathology profession. During the past few years, a steady flow of new-thinking Presidents and CEOs have taken control of laboratories, pathology group practices, and vendor companies. From CEO Ke…
“February 1, 1999 Intelligence: Late Breaking Lab News”
Are the financial fortunes of the national laboratories about to take a turn for the better? Financial analysts at FMR Corp. must think so. Last month the company disclosed that it had purchased 3 million common shares in Quest Diagnostics Incorporated, g…
AACC Convention Exhibits Point To New Lab Trends
CEO SUMMARY: This year the interesting trend at the AACC’s exhibit hall was modular laboratory automation. That’s a big change from the total laboratory automation solutions touted in past years. But watch out! The economics of this equipment have yet to be validated. It was also clea…
“August 17, 1998 Intelligence: Late Breaking Lab News”
THE DARK REPORT wants to thank those companies at the American Association of Clinical Chemistry convention in Chicago who invited us to special business briefings and other functions. It was an opportunity to meet both executives and the innovative customers of these companies who a…
Laboratory Trade Group Launches New Activities
CEO SUMMARY: Long overlooked by most of the laboratory industry, ACLA may be in the process of revolutionary change. Since David Sundwall, M.D., became President, ACLA has taken a more assertive stance on a wide variety of issues which affect all laboratories, not just ACLA members….
CURRENT ISSUE
Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.